All you need to know about the Electronic Procurement System for Public Health Supplies
- 04/07/2014
- Michalopoulou & Associates
- 5 Comments
Last Thursday June 19th, the presentation about ESIDIS, the national e-procurement system, which took part at the Business Association of Medical and Biotechnological Products highlighted a new era of public procurement in Greece. The presentation, led by a representative of…
Presentation Key Points on Regulation (EU) No 536/2014 of the European Parliament and the Council of 16 April 2014 on clinical trials on medicinal products for human use
- 20/06/2014
- Michalopoulou & Associates
- 8 Comments
The Regulation 536/2014’s purpose is the growth acceleration of pharmaceutical research via clinical trials in the European Union. Its provisions are directly applicable in the legal systems of the Member States (without requiring integration) and replace the national procedure of…
Latest Developments on the Competition & Regulation Environment in the Pharma Industry
- 10/06/2014
- Michalopoulou & Associates
- 4 Comments
I recently attended the annual EU Pharma Law Forum in Brussels at the 14th & 15th of May, 2014. Competition issues in the Pharma Industry have been key discussion points among EU officials and international law firms. Also highlighted was…
How does the new Law 4152/2013 affect late payments in commercial drug transactions?
- 30/05/2013
- Michalopoulou & Associates
- Comments Off on How does the new Law 4152/2013 affect late payments in commercial drug transactions?
The Directive 2011/7/EU was incorporated into the Greek Legislation by Law 4152/2013 foreseeing both transactions between private businesses and between private businesses and public authorities. It includes all medical supplies (consumables and pharmaceuticals) from government services (National Health System hospitals…